The diagnostic workup following a positive prostate-specific antigen test may lead to significant out-of-pocket costs for patients. Providers should incorporate costs into shared decision-making with patients; in parallel, policymakers and payers must identify solutions to mitigate financial burdens that risk widening existing disparities in prostate cancer care.
机构:
Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
Vickers, Andrew J.
Lilja, Hans
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Clin Chem, New York, NY 10021 USAMem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA